Category:
Chiral Intermediates
CAS NO:
870281-82-6
Standard:
USP,
/
CAL-101 (Idelalisib) is a potent, selective PI3K delta inhibitor developed for oncology. Its core synthesis involves advanced heterocyclic chemistry to target the PI3K pathway. Molecular Formula: C24H25ClN6O2; CAS No.: 892225-74-4.
Strictly monitor for hepatotoxicity and severe infections during clinical use. Store under -20°C in a dry, inert atmosphere to maintain stability and prevent degradation.